PRFX
PRFX
NASDAQ · Pharmaceuticals

Prf Technologies Ltd

$1.04
-0.06 (-5.45%)
As of Aug 8, 10:56 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,050.0% upside
Low Target $8.59
Average Target $11.96
High Target $16.97
Current Price $1.04
Current
$1.04
Target
$11.96
$8.59 $11.96 avg $16.97
Scenario Analysis
Bear Case
$8.59
726.0%
Low target
Base Case
$11.96
+1,050.0%
Avg target
Bull Case
$16.97
+1,531.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$17.95
-94.2% from high
52-Week Low
$0.97
+7.2% from low
Target vs 52W High
$11.96
-33.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%